The new lung cancer staging system.

PubWeight™: 6.30‹?› | Rank: Top 1%

🔗 View Article (PMID 19584208)

Published in Chest on July 01, 2009

Authors

Frank C Detterbeck1, Daniel J Boffa, Lynn T Tanoue

Author Affiliations

1: Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA. frank.detterbeck@yale.edu

Articles citing this

(truncated to the top 100)

Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest (2013) 4.96

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol (2015) 4.58

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20

Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. J Clin Oncol (2012) 2.31

Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality. J Thorac Cardiovasc Surg (2014) 2.04

Nodal Upstaging During Lung Cancer Resection Is Associated With Surgical Approach. Ann Thorac Surg (2015) 1.91

Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Clin Cancer Res (2012) 1.77

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma. Onco Targets Ther (2014) 1.58

Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med (2010) 1.39

CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential. Theranostics (2013) 1.35

Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg (2012) 1.23

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model. J Cancer Res Clin Oncol (2010) 1.23

Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer (2011) 1.18

Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. Interact Cardiovasc Thorac Surg (2011) 1.16

Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res (2009) 1.14

Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer. PLoS One (2013) 1.13

Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation. PLoS One (2014) 1.10

Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res (2011) 1.10

Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol (2012) 1.10

Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy. Int J Clin Exp Med (2012) 1.07

Treatment options for small cell lung cancer - do we have more choice? Br J Cancer (2010) 1.07

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol (2012) 1.06

Sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy for non-small cell lung cancer. J Cardiothorac Surg (2015) 1.05

Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed. J Thorac Oncol (2013) 1.04

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol (2015) 0.99

Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer. Lung (2013) 0.98

Early and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study. Interact Cardiovasc Thorac Surg (2012) 0.98

A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis. Mol Cancer (2010) 0.97

CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS One (2012) 0.97

Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Clin Cancer Res (2012) 0.97

Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manage (2011) 0.96

Content-based medical image retrieval: a survey of applications to multidimensional and multimodality data. J Digit Imaging (2013) 0.94

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma. Sci Rep (2014) 0.94

Progress in the management of limited-stage small cell lung cancer. Cancer (2013) 0.93

Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer. ISRN Oncol (2011) 0.91

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR. J Transl Med (2013) 0.91

Risk factors for postoperative complications after lung resection for non-small cell lung cancer in elderly patients at a single institution in China. J Thorac Dis (2014) 0.91

Growth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancy. Integr Biol (Camb) (2011) 0.91

Immunoglobulin G expression in lung cancer and its effects on metastasis. PLoS One (2014) 0.91

Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients. Diagn Pathol (2014) 0.89

Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer. PLoS One (2015) 0.88

Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm Med (2014) 0.88

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS One (2012) 0.88

Attaining proficiency with endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Cardiovasc Surg (2013) 0.88

Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett (2013) 0.88

Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study. PLoS One (2013) 0.87

Relationship between tumor size and disease stage in non-small cell lung cancer. BMC Cancer (2010) 0.87

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLoS One (2014) 0.87

Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer. J Thorac Oncol (2014) 0.87

Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol (2012) 0.87

A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol (2014) 0.86

Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. World J Surg Oncol (2014) 0.86

Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old. J Thorac Dis (2014) 0.86

Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis. BMC Cancer (2011) 0.86

Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. BMC Cancer (2011) 0.86

New dilemmas in small-cell lung cancer TNM clinical staging. Onco Targets Ther (2013) 0.86

Can lymph node evaluation be performed well by video-assisted thoracic surgery? J Cancer Res Clin Oncol (2014) 0.86

Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study. J Exp Clin Cancer Res (2011) 0.86

Complete response of 7 years' duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinoma. J Thorac Dis (2013) 0.86

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer. Br J Cancer (2012) 0.86

Novel image markers for non-small cell lung cancer classification and survival prediction. BMC Bioinformatics (2014) 0.86

Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung (2012) 0.86

Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC. J Cancer Res Clin Oncol (2015) 0.86

Tissue spray ionization mass spectrometry for rapid recognition of human lung squamous cell carcinoma. Sci Rep (2015) 0.86

Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins. Interact Cardiovasc Thorac Surg (2012) 0.84

TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer. PLoS One (2014) 0.84

No extensive experience in open procedures is needed to learn lobectomy by video-assisted thoracic surgery. Interact Cardiovasc Thorac Surg (2012) 0.84

Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients. Carcinogenesis (2014) 0.84

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomedicine (2013) 0.84

Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients. Clin Lung Cancer (2011) 0.84

Superior sulcus tumors (Pancoast tumors). Ann Transl Med (2016) 0.84

Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget (2016) 0.84

Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment. J Thorac Dis (2013) 0.83

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas. Onco Targets Ther (2015) 0.83

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in China. J Cancer Res Clin Oncol (2016) 0.83

Are There Any Additional Benefits to Performing Positron Emission Tomography/Computed Tomography Scans and Brain Magnetic Resonance Imaging on Patients with Ground-Glass Nodules Prior to Surgery? Tuberc Respir Dis (Seoul) (2017) 0.82

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT. BMC Pulm Med (2015) 0.82

Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer. Oncol Lett (2015) 0.82

RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer. Oncotarget (2015) 0.82

HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma. Onco Targets Ther (2015) 0.82

Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions. J Thorac Oncol (2010) 0.81

Principles of biopsy in suspected lung cancer: priority still based on invasion in the era of targeted therapy? J Thorac Dis (2013) 0.81

Which subgroup of patients with pathologic N2 non-small cell lung cancer benefit from surgery? J Cancer Res Clin Oncol (2012) 0.81

EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis. Sci Rep (2015) 0.81

A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection. PLoS One (2015) 0.81

Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer. Oncol Lett (2014) 0.81

Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer (2016) 0.81

Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort. J Cancer Res Clin Oncol (2011) 0.80

Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients. Cancer Chemother Pharmacol (2013) 0.80

Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma. Radiat Oncol (2011) 0.80

Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. J Thorac Dis (2013) 0.80

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer. Oncotarget (2016) 0.79

Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review. Onco Targets Ther (2015) 0.79

Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer (2011) 0.79

The self-overlap method for assessment of lung nodule morphology in chest CT. J Digit Imaging (2013) 0.79

The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel? EJC Suppl (2013) 0.79

Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgery. Oncotarget (2015) 0.78

The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume. BMC Cancer (2015) 0.78

Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit? Radiother Oncol (2017) 0.78

Functional imaging in lung cancer. Clin Physiol Funct Imaging (2013) 0.78

Articles by these authors

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.82

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36

Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77

Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99

Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59

The noninvasive staging of non-small cell lung cancer: the guidelines. Chest (2003) 1.57

The stage classification of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.28

Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18

An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 1.08

Update on cardiothoracic surgery resident job opportunities. Ann Thorac Surg (2010) 1.04

Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.03

Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg (2011) 0.95

Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92

Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90

Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol (2015) 0.90

Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89

Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg (2013) 0.87

Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg (2013) 0.85

Reacting to changes in staging designations in the 7th edition of the AJCC staging manual. Ann Surg Oncol (2011) 0.84

Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83

Pulmonary artery agenesis and Kommerell's diverticulum presenting with hemoptysis. Eur J Cardiothorac Surg (2008) 0.82

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg (2012) 0.81

Current surgical opinion of computed tomography for acute appendicitis. Surg Infect (Larchmt) (2004) 0.80

Learning curve to lymph node resection in minimally invasive esophagectomy for cancer. Innovations (Phila) (2014) 0.80

Anatomy, biology and concepts, pertaining to lung cancer stage classification. J Thorac Oncol (2009) 0.79

Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. J Surg Res (2013) 0.78

Extended use of extracorporeal membrane oxygenation after lung transplantation. J Thorac Cardiovasc Surg (2006) 0.78

Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology (Williston Park) (2006) 0.78

Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm. Ann Surg Oncol (2016) 0.77

Reply: To PMID 22835555. Ann Thorac Surg (2013) 0.75

Length of Stay From the Hospital Perspective: Practice of Early Discharge Is Not Associated With Increased Readmission Risk After Lung Cancer Surgery. Ann Surg (2017) 0.75

Lung cancer: evolving concepts. Semin Respir Crit Care Med (2008) 0.75

Intrathoracic hemorrhage after placement of a subpleural catheter. JAAPA (2011) 0.75

Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy. Oncology (Williston Park) (2006) 0.75

Transcervical wedge resection after transcervical extended mediastinal lymphadenectomy. Innovations (Phila) (2014) 0.75

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2003. A 43-year-old man with fever and night sweats. N Engl J Med (2003) 0.75

[Anatomy, biology and concepts, pertaining to lung cancer stage classification]. Zhongguo Fei Ai Za Zhi (2010) 0.75

Experience with thoracoscopic pneumonectomies at a single institution. Innovations (Phila) (2014) 0.75